Immuno-thermal ablations – boosting the anticancer immune response

بواسطة Slovak, Ryan, Ludwig, Johannes M., Gettinger, Scott N., Herbst, Roy S., Kim, Hyun S.
الحاوية / القاعدة J Immunother Cancer (2017)

Late recurrence of basaloid carcinoma initially treated as a small cell lung cancer

بواسطة Shumaster, Vladimir, Bae, Jason W., Gettinger, Scott N., Cai, Guoping, Kim, Anthony W.
منشور في 2013

SOX2-specific adaptive immunity and response to immunotherapy in non-small cell lung cancer

بواسطة Dhodapkar, Kavita M, Gettinger, Scott N, Das, Rituparna, Zebroski, Henry, Dhodapkar, Madhav V
منشور في 2013

Oncolytic virus immunotherapy: future prospects for oncology

بواسطة Raja, Junaid, Ludwig, Johannes M., Gettinger, Scott N., Schalper, Kurt A., Kim, Hyun S.
الحاوية / القاعدة J Immunother Cancer (2018)

Cryotherapy for nodal metastasis in NSCLC with acquired resistance to immunotherapy

بواسطة Adam, Lucas C., Raja, Junaid, Ludwig, Johannes M., Adeniran, Adebowale, Gettinger, Scott N., Kim, Hyun S.
الحاوية / القاعدة J Immunother Cancer (2018)

Preliminary safety, pharmacokinetics, and efficacy of regorafenib, cisplatin, and pemetrexed in patients with advanced non-squamous non-small cell lung cancers

بواسطة Hellmann, Matthew D, Sturm, Isrid, Trnkova, Zuzana Jirakova, Lettieri, John, Diefenbach, Konstanze, Rizvi, Naiyer A., Gettinger, Scott N.
الحاوية / القاعدة Clin Lung Cancer (2015)

Expression and clinical significance of PD-L1, B7-H3, B7-H4 and TILs in human small cell lung Cancer (SCLC)

بواسطة Carvajal-Hausdorf, Daniel, Altan, Mehmet, Velcheti, Vamsidhar, Gettinger, Scott N., Herbst, Roy S., Rimm, David L., Schalper, Kurt A.
الحاوية / القاعدة J Immunother Cancer (2019)

Comparison of Survival Rates After a Combination of Local Treatment and Systemic Therapy vs Systemic Therapy Alone for Treatment of Stage IV Non–Small Cell Lung Cancer

بواسطة Uhlig, Johannes, Case, Meaghan Dendy, Blasberg, Justin D., Boffa, Daniel J., Chiang, Anne, Gettinger, Scott N., Kim, Hyun S.
الحاوية / القاعدة JAMA Netw Open (2019)

Immune-related sarcoidosis observed in combination ipilimumab and nivolumab therapy

بواسطة Suozzi, Kathleen C., Stahl, Maximilian, Ko, Christine J., Chiang, Anne, Gettinger, Scott N., Siegel, Mark D., Bunick, Christopher G.
الحاوية / القاعدة JAAD Case Rep (2016)

Phase I/II Study of Inhaled Doxorubicin Combined with Platinum-Based Therapy for Advanced Non–Small Cell Lung Cancer

بواسطة Otterson, Gregory A., Villalona-Calero, Miguel A., Hicks, William, Pan, Xueliang, Ellerton, John A., Gettinger, Scott N., Murren, John R.
الحاوية / القاعدة Clin Cancer Res (2010)

Immune cell PD-L1 co-localizes with macrophages and is associated with outcome in PD-1 pathway blockade therapy

بواسطة Liu, Yuting, Zugazagoitia, Jon, Ahmed, Fahad Shabbir, Henick, Brian S., Gettinger, Scott N., Herbst, Roy S., Schalper, Kurt A., Rimm, David L.
الحاوية / القاعدة Clin Cancer Res (2019)

BRIEF REPORT: Immune checkpoint inhibitor associated pericarditis

بواسطة Altan, Mehmet, Toki, Maria I., Gettinger, Scott N., Carvajal-Hausdorf, Daniel E., Zugazagoitia, Jon, Sinard, John H., Herbst, Roy S., Rimm, David L.
الحاوية / القاعدة J Thorac Oncol (2019)

Clinical Features and Management of Acquired Resistance to PD-1 Axis Inhibitors in 26 Patients With Advanced Non–Small Cell Lung Cancer

بواسطة Gettinger, Scott N., Wurtz, Anna, Goldberg, Sarah B., Rimm, David, Schalper, Kurt, Kaech, Susan, Kavathas, Paula, Chiang, Anne, Lilenbaum, Rogerio, Zelterman, Daniel, Politi, Katerina, Herbst, Roy S.
الحاوية / القاعدة J Thorac Oncol (2018)

Ultrasensitive measurement of hotspot mutations in tumor DNA in blood using error-suppressed multiplexed deep sequencing

بواسطة Narayan, Azeet, Carriero, Nicholas J., Gettinger, Scott N., Kluytenaar, Jeannie, Kozak, Kevin R., Yock, Torunn I., Muscato, Nicole E., Ugarelli, Pedro, Decker, Roy H., Patel, Abhijit A.
منشور في 2012

Combination therapy with anti-CTLA4 and anti-PD1 leads to distinct immunologic changes in-vivo

بواسطة Das, Rituparna, Verma, Rakesh, Sznol, Mario, Boddupalli, Chandra Sekhar, Gettinger, Scott N., Kluger, Harriet, Callahan, Margaret, Wolchok, Jedd D, Halaban, Ruth, Dhodapkar, Madhav V., Dhodapkar, Kavita M.
الحاوية / القاعدة J Immunol (2014)

Programmed death ligand-1 expression in non-small cell lung cancer

بواسطة Velcheti, Vamsidhar, Schalper, Kurt A, Carvajal, Daniel E, Rimm, David L, Anagnostou, Valsamo K, Syrigos, Konstantinos N, Sznol, Mario, Herbst, Roy S, Gettinger, Scott N, Chen, Lieping, Syrigos, Konstantinos N
الحاوية / القاعدة Lab Invest (2013)

Phase 1 Trial of Pembrolizumab Administered Concurrently With Chemoradiotherapy for Locally Advanced Non–Small Cell Lung Cancer: A Nonrandomized Controlled Trial

بواسطة Jabbour, Salma K., Berman, Abigail T., Decker, Roy H., Lin, Yong, Feigenberg, Steven J., Gettinger, Scott N., Aggarwal, Charu, Langer, Corey J., Simone, Charles B., Bradley, Jeffrey D., Aisner, Joseph, Malhotra, Jyoti
الحاوية / القاعدة JAMA Oncol (2020)

Randomized Trial of Afatinib Plus Cetuximab Versus Afatinib Alone for First-Line Treatment of EGFR-Mutant Non–Small-Cell Lung Cancer: Final Results From SWOG S1403

بواسطة Goldberg, Sarah B., Redman, Mary W., Lilenbaum, Rogerio, Politi, Katerina, Stinchcombe, Thomas E., Horn, Leora, Chen, Everett H., Mashru, Sandeep H., Gettinger, Scott N., Melnick, Mary Ann, Herbst, Roy S., Baumgart, Megan A., Miao, Jieling, Moon, James, Kelly, Karen, Gandara, David R.
الحاوية / القاعدة J Clin Oncol (2020)

A Phase II trial of pembrolizumab for patients with melanoma or non-small cell lung cancer and untreated brain metastases

بواسطة Goldberg, Sarah B., Gettinger, Scott N., Mahajan, Amit, Chiang, Anne C., Herbst, Roy S., Sznol, Mario, Tsiouris, Apostolos John, Cohen, Justine, Vortmeyer, Alexander, Jilaveanu, Lucia, Yu, James, Hegde, Upendra, Speaker, Stephanie, Madura, Matthew, Ralabate, Amanda, Rivera, Angel, Rowen, Elin, Gerrish, Heather, Yao, Xiaopan, Chiang, Veronica, Kluger, Harriet M.
الحاوية / القاعدة Lancet Oncol (2016)

Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study

بواسطة Hellmann, Matthew D, Rizvi, Naiyer A, Goldman, Jonathan W, Gettinger, Scott N, Borghaei, Hossein, Brahmer, Julie R, Ready, Neal E, Gerber, David E, Chow, Laura Q, Juergens, Rosalyn A, Shepherd, Frances A, Laurie, Scott A, Geese, William J, Agrawal, Shruti, Young, Tina C, Li, Xuemei, Antonia, Scott J
الحاوية / القاعدة Lancet Oncol (2016)